From the International Vision Correction Research Centre (IVCRC), University-Eye-Clinic (Auffarth), Heidelberg, Augenklinik Ahaus (Gerl), Ahaus, Germany; Johnson & Johnson Vision (Tsai, Janakiraman, Jackson), Santa Ana, California, USA; AMO (Alarcon), Groningen, the Netherlands; University Eye Hospital (Dick), Bochum, Germany.
J Cataract Refract Surg. 2021 Feb 1;47(2):184-191. doi: 10.1097/j.jcrs.0000000000000399.
To evaluate the effectiveness and safety of 2 enhanced monofocal intraocular lenses (IOLs). The TECNIS Eyhance IOL (Model ICB00) was compared with a standard monofocal IOL (TECNIS Monofocal, Model ZCB00).
European multicenter study.
Prospective, bilateral, randomized, comparative/evaluator-masked, controlled study.
Adult subjects scheduled to undergo bilateral, primary phacoemulsification cataract extraction and posterior IOL implantation were randomized to receive the enhanced monofocal ICB00 IOL or the monofocal ZCB00 IOL in both eyes. Monocular endpoints at 6 months included distance-corrected intermediate visual acuity (DCIVA), photopic corrected distance visual acuity, and uncorrected intermediate visual acuity (UIVA). Binocular visual acuities, monocular corrected distance contrast sensitivity (first eyes), patient-reported outcomes, and safety were assessed at 6 months.
Overall, 139 patients were bilaterally implanted with the enhanced monofocal IOL (n = 67) or standard monofocal IOL (n = 72) and available for the 6-month visit. The enhanced monofocal IOL significantly improved mean monocular and binocular DCIVA and UIVA by at least 1-line logarithm of the minimum angle of resolution vs the standard monofocal IOL (all P ≤ .0001). Distance vision for the enhanced monofocal IOL was 20/20 or better and comparable with that of the standard monofocal lens at 6 months. Contrast sensitivity, photic phenomena outcomes, and rates of adverse events were similar between the 2 groups.
In patients undergoing cataract surgery, TECNIS Eyhance IOL Model ICB00 provided enhanced intermediate vision and similar distance performance and photic phenomena compared with a standard monofocal IOL, along with improved functional performance in daily life.
评估 2 种增强型单焦点人工晶状体(IOL)的有效性和安全性。将 Tecnis Eyhance IOL(ICB00 型)与标准单焦点 IOL(Tecnis Monofocal,ZCB00 型)进行比较。
欧洲多中心研究。
前瞻性、双侧、随机、对照/评估者盲法、对照研究。
计划行双侧、原发性超声乳化白内障吸除术和后房型 IOL 植入术的成年患者被随机分为双眼接受增强型单焦点 ICB00 IOL 或单焦点 ZCB00 IOL。6 个月时的单眼终点包括距离矫正中间视力(DCIVA)、光矫正远距视力和未矫正中间视力(UIVA)。6 个月时评估双眼视力、单眼矫正远距对比敏感度(第一只眼)、患者报告的结果和安全性。
共有 139 例患者(增强型单焦点 IOL 组 67 例,标准单焦点 IOL 组 72 例)双侧植入 IOL 并可进行 6 个月访视。与标准单焦点 IOL 相比,增强型单焦点 IOL 显著提高了至少 1 行最小分辨角对数视力的平均单眼和双眼 DCIVA 和 UIVA(均 P ≤.0001)。增强型单焦点 IOL 的远视力为 20/20 或更好,与标准单焦点镜片在 6 个月时相当。两组间对比敏感度、光觉现象结果和不良事件发生率相似。
在接受白内障手术的患者中,与标准单焦点 IOL 相比,Tecnis Eyhance IOL ICB00 型提供了增强的中间视力和类似的远距视力和光觉现象,同时提高了日常生活中的功能性表现。